drugset / Trial / NCT01183806

Effects of Exercise and Rivastigmine on Quality of Life of Alzheimer's Disease Patients

NCT01183806

Phase 3 Completed 40 enrolled Federal University of Bahia
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to determine whether a exercise program when combined with rivastigmine (Exelon patch) drug treatment compared with rivastigmine drug treatment alone would improve quality of life, ability to perform activities of daily living (ADL) and cognition in patients with Alzheimer's disease. Hypothesis: Ho: Rivastigmine drug treatment combined with exercise is not superior to rivastigmine drug treatment to improve quality of life of Alzheimer's disease patients. H1: Rivastigmine drug treatment combined with exercise is superior to rivastigmine drug treatment to improve quality of life of Alzheimer's disease patients, with an expectative of 15% of improvement in the quality of life scale measurement

Timeline

Start
2010-07
Primary completion
2012-01
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Background Rivastigmine Small molecule 10 mg Other

Indications